Page 9 - Rapid Detection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  Advances in testing is an extremely helpful step in controlling the COVID-19 pandemic, as increased testing access can identify cases quickly and reduce transmission.  “Screening testing, especially with the over-the-counter tests authorized today, is an important part of the country’s pandemic response—many schools, workplaces, communities, and other entities are setting up testing programs to quickly screen for COVID-19,” said Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health. “With the FDA’s authorization of multiple tests, the public can be as...

April 1st, 2021 Abbott The details on COVID-19 at-home testing are changing, and in a way that could have a major impact on our ability to deal with the pandemic. The FDA has now authorized multiple rapid tests for over the counter use (meaning, without a prescription or doctor pre-approval) to screen people who don't have symptoms of the disease. According to the FDA, "The addition of the OTC and POC tests for screening will give schools, workplaces, communities and others several options for serial screening tests that are accurate and reliable." The first tests cleared for at-home screenin...

Following recent U.S. Food and Drug Administration actions to support test development, the FDA took swift action this week to get more tests for screening asymptomatic individuals on the market. Today, the agency authorized several tests for over-the-counter (OTC) use without a prescription when used for serial screening.

WASHINGTON (dpa-AFX) - Becton, Dickinson and Company (BDX) said that it has received an emergency use authorization from the U.S. Food and Drug Administration for its rapid antigen test to be

BD Announces Collaboration with ImageMover for Rapid Antigen Test Reporting Reporting app helps facilitate SARS-CoV-2 testing and result reporting from BD Veritor™ Plus System News provided by Share this article Share this article FRANKLIN LAKES, N.J., March 9, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an agreement with ImageMover, a software platform that automates and simplifies medical data collection and management, to offer a companion mobile app that enables more streamlined reporting of SARS-CoV-...